ZESGER 2.5 MG TABLETS. 2.5mg Milligram Tablets

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Δραστική ουσία:

LISINOPRIL

Διαθέσιμο από:

McDermott Laboratories Ltd t/a Gerard Laboratories

INN (Διεθνής Όνομα):

LISINOPRIL

Δοσολογία:

2.5mg Milligram

Φαρμακοτεχνική μορφή:

Tablets

Τρόπος διάθεσης:

Product subject to prescription which may be renewed (B)

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

0000-00-00

Φύλλο οδηγιών χρήσης

PACKAGE LEAFLET: INFORMATION FOR THE USER 

ZESGER 2.5 MG, 5 MG, 10 MG AND 20 MG TABLETS 
(lisinopril) 

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE. 
- Keep this leaflet. You may need to read it again. 
- If you have any further questions, ask your doctor or pharmacist. 
- This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if their 
symptoms are the same as yours. 
- If any of the side effects gets serious, or if you notice any side
effects not listed in this leaflet, please 
tell your doctor or pharmacist. 

IN THIS LEAFLET: 
1. What Zesger is and what it is used for 
2. Before you take Zesger 
3. How to take Zesger 
4. Possible side effects 
5. How to store Zesger 
6. Further information 

1. WHAT ZESGER IS AND WHAT IT IS USED FOR 

Zesger belongs to a group of medicines called Angiotensin Converting
Enzyme (ACE) inhibitors. 
ACE inhibitors reduce blood pressure and widen blood vessels,
this allows the blood to flow more 
easily and reduces the effort needed to pump blood around the body.
Zesger Tablets are used to treat 
high blood pressure (hypertension), heart failure, and along
with other medicine, may be given 
following a heart attack. Zesger can also be given to diabetic
patients, to help treat conditions related to 
their diabetes such as hypertension and kidney problems. 

2. BEFORE YOU TAKE ZESGER 

DO NOT TAKE ZESGER IF 
•   you are allergic (hypersensitive) to Lisinopril or any of
the other ingredients of this medicine. 
•   you are allergic (hypersensitive) to any other ACE inhibitor
eg. Captopril, Enalapril, Ramipril. 
•   you, or a family member, have previously been treated with an
ACE inhibitor and have suffered an 
allergic reaction. Symptoms may include swelling of the face,
lips, tongue and/or throat with 
difficulty swallowing or breathing (angioedema). 
•   you are more than 3 months pregnant. (It is also better to
avoid Zesger in ear

Αρχείο Π.Χ.Π.

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Zesger 2.5 mg Tablets.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains lisinopril dihydrate equivalent to 2.5 mg anhydrous lisinopril.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
2.5 mg tablets are white, round, debossed with ‘2.5’ on one side and a breakline on the other.
The tablet can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Hypertension
Treatment of hypertension.
Heart Failure
Treatment of symptomatic heart failure.
_Acute myocardial infarction_
Short-term (6 weeks) treatment of haemodynamically stable patients within 24 hours of an acute myocardial infarction.
Renal Complications of Diabetes Mellitus
Treatment of renal disease in hypertensive patients with Type 2 diabetes mellitus and incipient nephropathy _(see_
_section 5.1, Pharmacodynamic properties)._
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Lisinopril tablets should be administered orally in a single daily dose. As with all other medication taken once daily,
lisinopril should be taken at approximately the same time each day. The absorption of lisinopril is not affected by food.
The dose should be individualised according to patient profile and blood pressure response (see section 4.4).
Hypertension
Lisinopril tablets may be used as monotherapy or in combination with other classes of antihypertensive therapy.
Use in Hypertensive Paediatric Patients aged 6- 16 years
The recommended initial dose is 2.5mg once daily in patients 20 to <50kg, and 5mg once daily in patients 50kg. The
dosage should be individually adjusted to a maximum of 20mg daily in patients weighing 20 to <50 kg, and 40mg in
patients 50 kg. Doses above 0.61mg/kg (or in excess of 40mg) have not�